CVE-2020-15797
Official description Straight from the sourceThe vendor's or NVD's own wording, published unedited. Authoritative, but often terse — it says what broke, rarely what to do.
NVD · uneditedA vulnerability has been identified in DCA Vantage Analyzer (All versions < V4.5 are affected by CVE-2020-7590. In addition, serial numbers < 40000 running software V4.4.0 are also affected by CVE-2020-15797). Improper Access Control could allow an unauthenticated attacker to escape from the restricted environment (“kiosk mode”) and access the underlying operating system. Successful exploitation requires direct physical access to the system.
Technical summary Written by usOur analysis, written from the advisory, the CVSS vector and the affected-version data. It adds context the advisory leaves out, and never invents facts that are not in the source.
dbcve analysis · high confidenceThe DCA Vantage Analyzer medical device contains an improper access control vulnerability that allows an unauthenticated attacker with direct physical access to escape the restricted kiosk mode environment and gain access to the underlying operating system. This affects devices running software versions prior to V4.5, with serial numbers below 40000 running V4.4.0 being specifically vulnerable to CVE-2020-15797.
Verify against the referenced sources before acting — the references below are authoritative for this CVE, this summary is not.
Affected products & versions What the vendor confirmedThe version ranges the vendor confirmed as vulnerable. If your version sits inside a range here, treat yourself as exposed until you have upgraded.
NVD · CPE data< 4.5.0.0CVSS breakdown How the score is builtThe industry scoring standard. It rates how the flaw is reached, what it takes to exploit, and what an attacker gains — the score is derived from those, not the other way round.
From the vector- Attack vector
- Physical
- Complexity
- Low
- Privileges
- None
- User interaction
- None
- Scope
- Unchanged
- Confidentiality
- High
- Integrity
- High
- Availability
- High
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Am I affected? How to checkSteps we derive from the advisory and the affected-version data, so you can decide whether this CVE reaches your setup. They are a guide, not a scan — your own configuration is the authority.
dbcve checksWork through these to decide whether this CVE applies to you.
-
Confirm device modelIdentify if the device is a Siemens DCA Vantage Analyzer medical device. Check the device label, packaging, or system information screen for the model name.Affected if Device is not a Siemens DCA Vantage Analyzer (not affected)
-
Check firmware versionAccess the device's system information or settings menu to view the installed firmware version. Compare this version number to the affected range of versions prior to 4.5.0.0.Affected if Firmware version is less than 4.5.0.0 (device may be affected)
-
Check serial numberLocate the serial number on the device label or within the device system information. Note that serial numbers below 40000 running V4.4.0 are specifically called out as vulnerable to CVE-2020-15797.Affected if Serial number is below 40000 and firmware is V4.4.0 (specifically vulnerable)
-
Verify kiosk mode configurationCheck if the device is configured to run in restricted kiosk mode or restricted access mode. This vulnerability specifically allows escaping from kiosk mode to access the underlying OS.Affected if Kiosk mode or restricted access mode is enabled (exploitation path exists)
-
Assess physical access exposureEvaluate whether the device is located in an area with uncontrolled physical access. This vulnerability requires direct physical access to exploit.Affected if Device is in an area with unrestricted physical access (exploitation is feasible)
The device is affected if it is a Siemens DCA Vantage Analyzer with firmware version prior to 4.5.0.0, especially with serial number below 40000 running V4.4.0, and is accessible to unauthorized physical access.
Generated from the published advisory. Verify against your own configuration.
Remediation Closing itWhat it takes to close this. Where a vendor fix exists we point at it; where none exists we say so plainly, and can build one. Effort estimates are scoped from the advisory, not from your codebase.
From vendor data4.5.0.0
Upgrade the DCA Vantage Analyzer software to version V4.5 or later, and verify that devices with serial numbers below 40000 are prioritized for the update. Since successful exploitation requires physical access, ensure devices are located in physically secured areas with restricted access.
- Consultation6.0 h
- Implementation3.0 h
- Testing6.0 h
- Review / QA3.0 h
An estimate, not a bill — we confirm scope with you before any work starts. Need it this week? Rush from $5,088.
Scan for this in your stack
Free · runs locallyCheck whether your project pulls in CVE-2020-15797 — or any other known-vulnerable package — straight from your lock files. Free and open source; it runs locally and uploads nothing.
References Go to the primary sourcePrimary sources — vendor advisories, patches and trackers. Where our summary and a reference disagree, the reference wins.
Primary sourcesPractitioner notes
ContributedPeer-ranked notes from engineers who’ve handled CVE-2020-15797 in production — separate from our analysis above.
The advisory tells you what broke. It rarely tells you what actually worked. If you’ve dealt with this one, that detail is what the next engineer is searching for.
- The version that genuinely resolved it — not the one the vendor claimed
- A config change or rule that shut the vector down
- A gotcha in the upgrade path that cost you an afternoon
No notes yet
Be the first to add a field note for this CVE — a mitigation you’ve verified, a version caveat, or a link to a working fix. Sign in above to contribute.
A place for practitioners to share what actually worked: a mitigation you’ve tested, a configuration change, a version- or environment-specific caveat, or a link to a verified patch. The most useful notes rise to the top as peers upvote them, so the signal stays high.
- Verified mitigations, workarounds, and config changes
- Version or environment caveats, and links to real fixes
- No weaponised exploit code, or anything meant to cause harm
- No spam, self-promotion, credentials, or personal data